Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition
KAUST Grant NumberKUK-I1-012-43
Permanent link to this recordhttp://hdl.handle.net/10754/598665
MetadataShow full item record
AbstractSchistosoma mansoni and Plasmodium falciparum are pathogen parasites that spend part of their lives in the blood stream of the human host and are therefore heavily exposed to fluxes of toxic reactive oxygen species (ROS). SmTGR, an essential enzyme of the S. mansoni ROS detoxification machinery, is known to be inhibited by Auranofin although the inhibition mechanism has not been completely clarified. Auranofin also kills P. falciparum, even if its molecular targets are unknown. Here, we used computational and docking techniques to investigate the molecular mechanism of interaction between SmTGR and Auranofin. Furthermore, we took advantage of the homology relationship and of docking studies to assess if PfTR, the SmTGR malaria parasite homologue, can be a putative target for Auranofin. Our findings support a recently hypothesized molecular mechanism of inhibition for SmTGR and suggest that PfTR is indeed a possible and attractive drug target in P. falciparum. © 2011 Elsevier Inc.
CitationCaroli A, Simeoni S, Lepore R, Tramontano A, Via A (2012) Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition. Biochemical and Biophysical Research Communications 417: 576–581. Available: http://dx.doi.org/10.1016/j.bbrc.2011.12.009.
SponsorsWe thank the members of the Fondazione Roma Research Unit led by Prof. Maurizio Brunori for useful discussions and Prof. Arthur Lesk for critically reading the manuscript. This work was partially supported by Award number KUK-I1-012-43 made by King Abdullah University of Science and Technology (KAUST), FIRB Proteomica, Ministery of Health Grant Contract No. Onc_Ord 25/07, Fondazione Roma and the IIT SEED project.
CollectionsPublications Acknowledging KAUST Support
- Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.
- Authors: Huang HH, Day L, Cass CL, Ballou DP, Williams CH Jr, Williams DL
- Issue date: 2011 Jul 5
- Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
- Authors: Huang J, Hua W, Li J, Hua Z
- Issue date: 2015 Oct
- New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
- Authors: Sannella AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF, Majori G, Severini C
- Issue date: 2008 Mar 19
- Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects.
- Authors: Angelucci F, Sayed AA, Williams DL, Boumis G, Brunori M, Dimastrogiovanni D, Miele AE, Pauly F, Bellelli A
- Issue date: 2009 Oct 16
- Comparative modeling of thioredoxin glutathione reductase from Schistosoma mansoni: a multifunctional target for antischistosomal therapy.
- Authors: Sharma M, Khanna S, Bulusu G, Mitra A
- Issue date: 2009 Feb